- Prediction of Cancer Incidence and Mortality in Korea, 2013
-
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS
- KMID: 2167603
- Cancer Res Treat.
- 2013 Mar;45(1):15-21.
PURPOSE: To estimate the current cancer burden in Korea, cancer incidence and mortality rates were projected for the year 2013. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2010 were... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
-
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS
- KMID: 2167602
- Cancer Res Treat.
- 2013 Mar;45(1):1-14.
PURPOSE: This article gives an overview of nationwide cancer statistics, including incidence, mortality, survival and prevalence, and their trends in Korea based on 2010 cancer incidence data. MATERIALS AND METHODS: Incidence... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
-
Kim KH, Song SY, Lim KH, Han SS, Kim SH, Cho JH, Park CW, Lee S, Lee HY
- KMID: 2167611
- Cancer Res Treat.
- 2013 Mar;45(1):74-77.
Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Paraneoplastic Pemphigus Associated with Esophageal Squamous Cell Carcinoma
-
Cho JH, Kim NJ, Ko SM, Kim C, Ahn HK, Yun J, Park YH
- KMID: 2167610
- Cancer Res Treat.
- 2013 Mar;45(1):70-73.
Paraneoplastic pemphigus is an autoimmune blistering and erosive mucocutaneous syndrome associated with underlying neoplasm. It is primarily associated with lymphoproliferative disorders, and uncommonly with malignancies of epithelial origin. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
-
Park KW, Jung ES, Kim DG, Yoo YK, Hong TH, Lee IS, Koh YH, Kim JH, Lee MA
- KMID: 2167609
- Cancer Res Treat.
- 2013 Mar;45(1):63-69.
PURPOSE: There are three types of bile duct cancer, intrahepatic cholangiocarcinoma (ICC), hilar cholangiocarcinoma (HC), and extrahepatic cholangiocarcinoma (EHC). Despite different clinical presentation, the same protocol has been used in... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
-
Lee HJ, Kim HS, Park NH, Chung HH, Kim JW, Song YS
- KMID: 2167606
- Cancer Res Treat.
- 2013 Mar;45(1):40-47.
PURPOSE: The purpose of this study is to evaluate the efficacy and toxicity of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in heavily pretreated patients with recurrent epithelial ovarian cancer (EOC). MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer
-
Jeong BK, Huh SJ, Choi DH, Park W, Bae DS, Kim BG
- KMID: 2167607
- Cancer Res Treat.
- 2013 Mar;45(1):48-54.
PURPOSE: In some unusual cases, in patients with cervical cancer, an elevation of squamous cell carcinoma antigen (SCC-Ag) was not observed at diagnosis but was observed on recurrence, or vice... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy
-
Kim ST, Park KH, Kim JS, Shin SW, Kim YH
- KMID: 2167608
- Cancer Res Treat.
- 2013 Mar;45(1):55-62.
PURPOSE: Activating mutation of the KRAS oncogene is an established negative predictor for anti-epidermal growth factor receptor (anti-EGFR) therapies in metastatic colorectal cancer (CRC). However, KRAS mutation as a prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy
-
Lee JH, Song JH, Lee SN, Kang JH, Kim MS, Sun DI, Kim YS
- KMID: 2167605
- Cancer Res Treat.
- 2013 Mar;45(1):31-39.
PURPOSE: We wanted to evaluate the role of postoperative chemoradiotherapy (CRT) for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). MATERIALS AND METHODS: From March 1993... -
- CITED
-
- Close
- SHARE
-
- Close
- Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma
-
Park JS, Choi JY, Moon SH, Ahn YC, Lee J, Kim D, Kim K, Shim YM
- KMID: 2167604
- Cancer Res Treat.
- 2013 Mar;45(1):22-30.
PURPOSE: Parameters of positron emission tomography-computed tomography (PET-CT) were compared with the results of histopathologic examination in order to determine which can provide an objective indication of response after neoadjuvant... -
- CITED
-
- Close
- SHARE
-
- Close
